Compare EVO & EVER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVO | EVER |
|---|---|---|
| Founded | 1993 | 2008 |
| Country | Germany | United States |
| Employees | 4553 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 878.3M |
| IPO Year | N/A | 2018 |
| Metric | EVO | EVER |
|---|---|---|
| Price | $1.96 | $25.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $7.00 | ★ $27.00 |
| AVG Volume (30 Days) | 44.2K | ★ 729.3K |
| Earning Date | 04-08-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 198.86 |
| EPS | N/A | ★ 0.51 |
| Revenue | N/A | ★ $163,349,000.00 |
| Revenue This Year | $1.37 | $14.73 |
| Revenue Next Year | $10.05 | $11.51 |
| P/E Ratio | ★ N/A | $48.04 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.94 | $13.88 |
| 52 Week High | $4.42 | $28.73 |
| Indicator | EVO | EVER |
|---|---|---|
| Relative Strength Index (RSI) | 25.35 | 54.76 |
| Support Level | N/A | $23.67 |
| Resistance Level | $3.36 | $27.10 |
| Average True Range (ATR) | 0.10 | 1.43 |
| MACD | -0.05 | -0.29 |
| Stochastic Oscillator | 1.02 | 19.79 |
Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.
EverQuote Inc operates an online marketplace for insurance shopping, connecting consumers with insurance providers, including carriers and agents. Its marketplace is powered by proprietary data and technology platform that delivers high-intent, pre-validated consumer referrals aligned with insurers underwriting and profitability requirements. The platform provides transparency and campaign management tools, enabling providers to evaluate marketing spend performance and manage return on investment. Consumers can visit insurance provider websites, engage by phone, or submit data to receive quotes. Services are free for consumers, and the company derives revenue principally from consumer inquiries sold as referrals to insurance providers. It derives a majority of revenue from Direct channels.